• PARP7 Inhibition Stabilizes STAT1/STAT2 and Relieves EAE in

  2026-06-07

  Xu et al. reveal that PARP7 suppresses type I interferon signaling by promoting the autophagic degradation of STAT1 and STAT2 via ADP-ribosylation. Inhibiting PARP7 restores STAT1/STAT2 levels, enhancing interferon responses and alleviating experimental autoimmune encephalomyelitis (EAE) symptoms in mice, pointing to new therapeutic avenues for multiple sclerosis research.

• Epacadostat (INCB024360) in Immuno-Oncology: Protocols & Opt

  2026-06-06

  Epacadostat (INCB024360) unlocks precision immuno-oncology workflows by targeting IDO1-driven immune suppression. This article bridges innovative whole-blood stimulation protocols with actionable troubleshooting and advanced use-cases to help researchers maximize immune modulation and assay performance.

• Vitamin D/VDR Signaling Drives Endometrial Decidualization

  2026-06-05

  A recent study delineates how 1,25-dihydroxy vitamin D3 (Calcitriol) enhances decidualization of human endometrial stromal cells via vitamin D receptor (VDR)-mediated mechanisms. These findings clarify the molecular crosstalk between vitamin D signaling and estrogen pathways, informing future research on endometrial receptivity and infertility.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation

  2026-06-05

  Song et al. (2025) reveal that targeted activation of TRPV1+ peripheral somatosensory nerves at the nape rapidly suppresses systemic inflammation via a somato-autonomic reflex. This study uncovers a neural-immune circuit, providing mechanistic insight with implications for translational inflammation research and experimental protocol design.

• Oridonin Modulates Osteoclastogenesis via MAPK/NF-κB Pathway

  2026-06-04

  This study demonstrates that oridonin can both suppress thioacetamide-induced osteoclastogenesis and restore osteoblast differentiation by targeting the MAPK/NF-κB and BMP-2/RUNX2 pathways, respectively. The findings provide mechanistic insight into dual-action strategies for osteoporosis, highlighting new directions for anti-inflammatory and bone-protective research.

• β-Elemene in Obesity and Neuroprotection: Applied Protocols

  2026-06-04

  β-Elemene bridges adipogenesis inhibition and neuroprotection, offering researchers a rare tool for dissecting metabolic and neural pathways. This guide translates the latest reference study and benchmarking resources into robust workflows, actionable protocol parameters, and troubleshooting strategies for advanced cell biology applications.

• 2'3'-cGAMP (sodium salt): Applied Workflows in cGAS-STING Re

  2026-06-03

  2'3'-cGAMP (sodium salt) enables precision activation of the cGAS-STING pathway, supporting robust studies of innate immune signaling and immunotherapy. Its reproducible performance, water solubility, and benchmark potency make it indispensable for dissecting type I interferon responses and overcoming experimental bottlenecks.

• Substance P: Applied Workflows for Pain Transmission Researc

  2026-06-03

  Substance P is a gold-standard tachykinin neuropeptide enabling precise, reproducible modeling of pain, inflammation, and immune signaling in CNS research. This guide details experimental workflows, spectral interference management, and troubleshooting strategies that maximize data quality using APExBIO’s high-purity Substance P.

• Optimizing Immunoassays with TBST (Tris-Buffered Saline and

  2026-06-02

  TBST (Tris-Buffered Saline and Tween 20) is the backbone of high-sensitivity immunoassays, delivering exceptional signal-to-noise ratio enhancement in workflows from Western blotting to immunofluorescence. Discover experimental strategies and troubleshooting insights that maximize its utility and reliability in antibody-based detection.

• BIBP 3226 trifluoroacetate: Advancing NPY/NPFF System Resear

  2026-06-02

  BIBP 3226 trifluoroacetate empowers translational researchers to dissect the mechanistic role of NPY/NPFF signaling in cardiac arrhythmia and anxiety models. Its high selectivity and robust performance enable reproducible results in complex coculture and pathway modulation assays, positioning it as an indispensable tool for modern neurocardiovascular research.

• Micro- and Nanoplastics Drive Pulmonary Fibrosis via FXR-YAP

  2026-06-01

  This study systematically demonstrates that inhaled microplastics and nanoplastics, especially polystyrene nanoplastics, significantly increase the risk of pulmonary fibrosis in mice and cell models. The research highlights the size- and polymer-dependent toxicity of these pollutants and identifies FXR-YAP1 signaling disruption as a key mechanistic driver, providing mechanistic insights for respiratory risk assessment.

• Tacrolimus (FK506): Potent Calcineurin Inhibitor for Immune

  2026-06-01

  Tacrolimus (FK506) is a nanomolar-potency macrolide immunosuppressant that selectively inhibits calcineurin activity. It reliably suppresses T-cell activation and cytokine secretion in transplantation immunology research. Its high solubility and validated dosing make it a preferred tool for immune response modulation.

• Isoprinosine (Inosine Pranobex): Advanced Insights into Immu

  2026-05-31

  Explore the multifaceted role of Isoprinosine in immunotherapy and viral inhibition, focusing on its unique impact on herpesvirus nuclear egress and translational assay design. This article provides a deeper scientific context for inosine pranobex, advancing beyond conventional analyses.

• Cathepsin B Inhibitor CA-074: Practical Guide for Research U

  2026-05-30

  Cathepsin B inhibitor CA-074 (SKU A1926) addresses the need for highly selective, low-cytotoxicity inhibition of cathepsin B in studies of cancer metastasis, neurodegeneration, and immune modulation. CA-074 is best applied where precise blockade of cathepsin B activity is required, but should not be used as a pan-cathepsin inhibitor or in applications where long-term solution stability is essential.

• Lenalidomide (CC-5013): Optimizing Workflows in Myeloma Rese

  2026-05-29

  Lenalidomide (CC-5013) empowers researchers to unlock synergistic immune activation and angiogenesis inhibition, especially in advanced multiple myeloma models. This guide delivers actionable protocols, troubleshooting strategies, and the latest insights into DOT1L inhibition synergy, maximizing both scientific rigor and translational impact with APExBIO’s trusted reagent.

16080 records 1/1072 page Next 12345 下5页 Last page